Key result
While incorporating MRI-detected cerebral microbleeds into anticoagulation decision-making for atrial fibrillation is promising, larger prospective studies are needed to validate its clinical utility.
Why the study?
Does MRI for risk stratification improve anticoagulation decision making in patients with atrial fibrillation?
Does MRI for risk stratification improve anticoagulation decision making in patients with atrial fibrillation?
MRI is a promising tool for risk stratification in atrial fibrillation anticoagulation decisions, though further data are needed.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Wilson et al. (2014) conducted an editorial in Atrial fibrillation. MRI screening for cerebral microbleeds was evaluated. While incorporating MRI-detected cerebral microbleeds into anticoagulation decision-making for atrial fibrillation is promising, larger prospective studies are needed to validate its clinical utility.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: